Tempest Therapeutics (TPST) Net Income (2012 - 2026)

Tempest Therapeutics has disclosed Net Income across 15 years of filings, most recently posting -$5.2 million for Q2 2026.

• In Q2 2026, Net Income rose 34.47% year-over-year to -$5.2 million; the TTM figure through Jun 2026 stood at -$15.4 million (up 56.4% YoY), while the FY2025 annual figure was -$21.3 million, up 38.45% from the prior year.
• Net Income came in at -$5.2 million for Q2 2026 at Tempest Therapeutics, down from $1.4 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $1.4 million in Q4 2025 to a low of -$11.1 million in Q1 2025.
• Average Net Income over 5 years is -$6.7 million, with a median of -$7.9 million recorded in 2023.
• Year-over-year, Net Income slumped 216.6% in 2024 and jumped 126.72% in 2025.
• Over 5 years, Net Income stood at -$1.9 million in 2022, then climbed by 9.1% to -$1.7 million in 2023, then tumbled by 216.6% to -$5.4 million in 2024, then surged by 126.72% to $1.4 million in 2025, then tumbled by 465.34% to -$5.2 million in 2026.
• Per Business Quant data, the three most recent Net Income figures were -$5.2 million in Q2 2026, $1.4 million in Q4 2025, and -$3.6 million in Q3 2025.